Litigation Details for UCB, Inc. v. Alza Corporation (D. Del. 2015)
✉ Email this page to a colleague
UCB, Inc. v. Alza Corporation (D. Del. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-12-21 |
Court | District Court, D. Delaware | Date Terminated | 2016-03-17 |
Cause | 28:2201 Declaratory Judgment | Assigned To | Sue Lewis Robinson |
Jury Demand | None | Referred To | |
Patents | 6,403,120; 6,419,958 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in UCB, Inc. v. Alza Corporation
Details for UCB, Inc. v. Alza Corporation (D. Del. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-12-21 | 1 | 22-104, Osmotica listed United States Patent Numbers 6,403,120 and 6,419,958 in the FDA’s publication…unenforceability of United States Patent Number 6,440,457 (“the ’457 patent”) under 28 U.S.C. §§ 2201 and… TH E PATENT IN SUIT 9. The United States Patent and Trademark Office (“…Evaluations (the “Orange Book”), as patents “with respect to which a claim of patent infringement could reasonably…that led to the ’457 patent. Thus, any claim for infringement of the ’457 patent is barred, in whole | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |